Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06164327. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19/CD22-Dual-STAR-T for Patients With B Cell Acute Leukemia(B-ALL)
ClinicalTrials.gov study NCT04508842. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05800977. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
ClinicalTrials.gov study NCT06649812. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 )
ClinicalTrials.gov study NCT07101328. IPD Sharing: NO. Countries: 12. Publications: 0.
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
ClinicalTrials.gov study NCT06991114. IPD Sharing: UNDECIDED. Countries: 8. Publications: 0.
A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07068906. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT04205838. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT06247501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00575406. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liquid Biopsy in Mature B-cell Tumors
ClinicalTrials.gov study NCT03280394. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT07335328. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05221645. IPD Sharing: NO. Countries: 1. Publications: 0.
The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04169932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
ClinicalTrials.gov study NCT05934838. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of IBI110 Single Agent and in Combination With Sintilimab in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)
ClinicalTrials.gov study NCT05039658. IPD Sharing: NO. Countries: 1. Publications: 0.
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05097443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT06594640. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT01126502. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
ClinicalTrials.gov study NCT03114865. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.